Better bleeding control

In a controlled, hepatic injury model, TenaTac® reduced the severity of bleeding at 6 minutes by 53% vs. comparator, and by over 90% at 9 minutes. (p=0.002).​ Study NWPSSLNOV2017, data on file

Better adhesion

In a controlled, hepatic injury model, TenaTac® (N=31) shows consistently stronger adhesion to the liver than comparator (N=21). Study NWPSSLNOV2017, data on file